These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 5667022)

  • 21. [Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46].
    Yoshida T; Takano M; Tamura A; Kubota H; Suzuki N
    Masui; 1970 May; 19(5):515-22. PubMed ID: 4393894
    [No Abstract]   [Full Text] [Related]  

  • 22. Bretylium: a prototype for future development of antidysrhythmic agents.
    Patterson E; Lucchesi BR
    Am Heart J; 1983 Aug; 106(2):426-31. PubMed ID: 6869235
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cardiovascular effects of alprenolol(beta-blockade) under halothane anesthesia].
    Yoshida T; Kubota M; Tamura A; Suzuki K; Furukawa Y
    Masui; 1969 Nov; 18(11):1071-8. PubMed ID: 4391283
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of various antiarrhythmic drugs on the daunomycin-induced arrhythmia in the hamster.
    Herman EH; Schein P; Taylor O; Waravdekar VS
    Proc Soc Exp Biol Med; 1970 Jan; 133(1):69-72. PubMed ID: 5412364
    [No Abstract]   [Full Text] [Related]  

  • 25. The properties of beta adrenergic blocking agents.
    Shanks RG
    Ir J Med Sci; 1969 Aug; 2(8):351-67. PubMed ID: 5364972
    [No Abstract]   [Full Text] [Related]  

  • 26. A critical evaluation of three methods for the study of adrenergic beta-blocking and anti-arrhythmic agents.
    Vargaftig B; Coignet JL
    Eur J Pharmacol; 1969 Apr; 6(1):49-55. PubMed ID: 4389065
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect on intracellular atrial potentials of bretylium in relation to its local anaesthetic potency.
    Papp JG; Williams EM
    Br J Pharmacol; 1969 Feb; 35(2):P352-3. PubMed ID: 5774055
    [No Abstract]   [Full Text] [Related]  

  • 28. [Modification of ouabain-induced arrhythmia test in anesthesized guinea pigs].
    Luca C; Sardi B; Valli L; Pacei E
    Cardiologia; 1987 Jan; 32(1):85-8. PubMed ID: 3107817
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellular basis and clinical evaluation of antiarrhythmic therapy.
    Vander Ark CR; Reynolds EW
    Med Clin North Am; 1969 Nov; 53(6):1297-308. PubMed ID: 4902920
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacological study of a new beta adrenergic inhibitor (S 2395)].
    Laubie M; Schmitt H; Mouillé P; Cheymol G; Gilbert JC
    C R Acad Hebd Seances Acad Sci D; 1971 Oct; 273(14):1234-6. PubMed ID: 4399407
    [No Abstract]   [Full Text] [Related]  

  • 31. The experimental basis for the choice of an anti-arrhythmic drug.
    Vaughan Williams EM
    Adv Cardiol; 1970; 4():275-89. PubMed ID: 4395423
    [No Abstract]   [Full Text] [Related]  

  • 32. [Comparative evaluation of the effectiveness of traditional antiarrhythmic beta-blocking drugs].
    Uggeri E; Guidi GC; Chilloni G
    Minerva Anestesiol; 1969 Apr; 35(4):429-36. PubMed ID: 5790003
    [No Abstract]   [Full Text] [Related]  

  • 33. Propranolol (Inderal) in experimentally-induced cardiac arrhythmias.
    Lucchesi BR; Whitsitt LS; Brown NL
    Can J Physiol Pharmacol; 1966 Jul; 44(4):543-7. PubMed ID: 5966564
    [No Abstract]   [Full Text] [Related]  

  • 34. Anti-arrhythmic, local anaesthetic, and adrenergic blocking activity of some beta-receptor antagonists.
    Hermansen K
    Br J Pharmacol; 1969 Mar; 35(3):476-86. PubMed ID: 5809739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 36. [The effect of anti-adrenergic drugs on the concentration of adenylic nucleotides in rabbit myocardia].
    Chekman IS; Tumanov VA
    Farmakol Toksikol; 1973; 36(5):548-50. PubMed ID: 4150862
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug.
    Giudicelli JF; Schmitt H; Boissier JR
    J Pharmacol Exp Ther; 1969 Jul; 168(1):116-26. PubMed ID: 5792677
    [No Abstract]   [Full Text] [Related]  

  • 38. A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function.
    Papp JG; Williams EM
    Br J Pharmacol; 1969 Oct; 37(2):391-9. PubMed ID: 4390670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of the effects of bretylium, lignocaine and propranolol on experimental cardiac arrhythmias.
    Allen JD; Shanks RG; Zaidi SA
    Br J Pharmacol; 1969 Oct; 37(2):526P-527P. PubMed ID: 5348446
    [No Abstract]   [Full Text] [Related]  

  • 40. Bretylium tosylate.
    Cooper JA; Frieden J
    Am Heart J; 1971 Nov; 82(5):703-6. PubMed ID: 4940224
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.